Re-consent of the UK-PBC Research Cohort
As part of the re-consenting process, the revised Participant Information Sheet (PIS) and Informed Consent Form (ICF) were sent to each and every participant at the beginning of April 2016. We …
CymaBay Therapeutics closes Its Phase 2 Study of MBX-8025 in Patients With Primary Biliary Cholangitis (PBC) early
After review of safety and efficacy data, CymaBay Therapeutics stopped their Phase 2 study of MBX-8025 in Patients With Primary Biliary Cholangitis (PBC) early, due to data clearly demonstrating proof-of-concept …